End Stage Kidney Disease research hub
5 indexed studies · 4 currently recruiting
- recruitingPHASE2, PHASE3
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
This study is testing a new medicine, CSL300, for adults with advanced kidney disease on dialysis. It aims to see if CSL300 can improve heart health and is safe, especially for those with existing heart conditions or diabetes.
United States · Argentina · Australia - recruitingPHASE4
Randomised Evaluation of Sodium Dialysate Levels on Vascular Events
This study looks at how different sodium levels in dialysis fluid affect people with advanced kidney disease. It compares two common sodium levels (137mmol/l and 140mmol/l) to see which might be better for preventing serious heart problems or death.
Australia · Canada · Germany - recruiting
Validating Novel, Non-contrast Cardiac MRI Imaging in Haemodialysis Patients
This study looks at a new MRI scan for people on dialysis to measure heart scarring. We want to see if this new scan, called native T1 mapping, accurately shows how much scarring is really there. This could help us understand and treat heart problems in dialysis patients better.
United Kingdom - recruitingPHASE3
meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis
This study looks at a new type of medicine called Empagliflozin for people with kidney failure on peritoneal dialysis. It aims to see if the medicine is safe and how it works to protect remaining kidney function over two weeks.
Canada - active not recruitingNA
Symptom Management in Patients on Dialysis
This study looks at new ways to help people on dialysis manage their symptoms better. It tests if using electronic surveys and an online hub can improve how symptoms like pain, tiredness, or anxiety are spotted and managed in kidney disease.
Canada